These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Normokalemic hyperaldosteronism in patients with resistant hypertension. Benchetrit S; Bernheim J; Podjarny E Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302 [TBL] [Abstract][Full Text] [Related]
3. [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension]. Mosso L; Fardella C; Montero J; Rojas P; Sánchez O; Rojas V; Rojas A; Huete A; Soto J; Foradori A Rev Med Chil; 1999 Jul; 127(7):800-6. PubMed ID: 10668287 [TBL] [Abstract][Full Text] [Related]
4. [Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension]. Skrabal F; Mauser R Wien Klin Wochenschr; 1976 Dec; 88(23):777-81. PubMed ID: 1014711 [TBL] [Abstract][Full Text] [Related]
5. The integrated concentration of plasma renin activity and aldosterone in essential hypertension. Kowarski AA; Edwin CM; Akesode AP; Piotrowski LS; Hamilton BP Johns Hopkins Med J; 1978 Feb; 142(2):35-8. PubMed ID: 625094 [TBL] [Abstract][Full Text] [Related]
6. [11 beta-hydroxysteroid dehydrogenase type 2 activity in Chilean patients with hypertension]. Mosso L; Carvajal C; Campino C; Rojas A; González A; Barraza A; Montero J; Fardella C Rev Med Chil; 2002 Nov; 130(11):1201-8. PubMed ID: 12587501 [TBL] [Abstract][Full Text] [Related]
7. Common variants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertension. Hannila-Handelberg T; Kontula K; Tikkanen I; Tikkanen T; Fyhrquist F; Helin K; Fodstad H; Piippo K; Miettinen HE; Virtamo J; Krusius T; Sarna S; Gautschi I; Schild L; Hiltunen TP BMC Med Genet; 2005 Jan; 6():4. PubMed ID: 15661075 [TBL] [Abstract][Full Text] [Related]
8. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism. Trenkel S; Seifarth C; Schobel H; Hahn EG; Hensen J Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):80-5. PubMed ID: 11928071 [TBL] [Abstract][Full Text] [Related]
9. The diagnosis of primary aldosteronism and separation of two major subtypes. Weinberger MH; Fineberg NS Arch Intern Med; 1993 Sep; 153(18):2125-9. PubMed ID: 8379804 [TBL] [Abstract][Full Text] [Related]
10. Screening for primary aldosteronism--normal ranges for aldosterone and renin in three South African population groups. Rayner BL; Myers JE; Opie LH; Trinder YA; Davidson JS S Afr Med J; 2001 Jul; 91(7):594-9. PubMed ID: 11544978 [TBL] [Abstract][Full Text] [Related]
11. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism. Prejbisz A; Postuła M; Cybulska I; Dobrucki T; Kabat M; Peczkowska M; Janas J; Janaszek-Sitkowska H; Makowiecka-Cieśla M; Januszkiewicz A Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298 [TBL] [Abstract][Full Text] [Related]
13. [The behavior of serum angiotensin-converting enzyme in normotensive subjects, in subjects with essential hypertension and in subjects with primary hyperaldosteronism on the orthostatic test]. Letizia C; Cerci S; De Ciocchis A; Tarsitani P; D'Ambrosio C; Coassin S; Scavo D Minerva Cardioangiol; 1992 Dec; 40(12):505-11. PubMed ID: 1338343 [TBL] [Abstract][Full Text] [Related]
14. [Effect of insulin in hypertension with high and low levels of renin]. Sindelka G; Widimský J; Prázný M; Kasalová Z; Skrha J Cas Lek Cesk; 2001 Apr; 140(7):205-8. PubMed ID: 11374224 [TBL] [Abstract][Full Text] [Related]
15. Relationships of plasma renin levels with renal function in patients with primary aldosteronism. Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA Clin J Am Soc Nephrol; 2007 Jul; 2(4):722-31. PubMed ID: 17699488 [TBL] [Abstract][Full Text] [Related]
16. Aldosterone-to-renin ratio and home blood pressure in subjects with higher and lower sodium intake: the Ohasama study. Satoh M; Kikuya M; Hara A; Ohkubo T; Mori T; Metoki H; Utsugi MT; Hirose T; Obara T; Inoue R; Asayama K; Totsune K; Hoshi H; Satoh H; Imai Y Hypertens Res; 2011 Mar; 34(3):361-6. PubMed ID: 21124331 [TBL] [Abstract][Full Text] [Related]
17. Relationship of basal plasma norepinephrine to blood pressure, plasma renin activity, mineralocorticoids, and plasma volume in essential hypertension. Chobanian AV; Gavras H; Melby JC; Gavras I; Jick H Trans Assoc Am Physicians; 1978; 91():368-80. PubMed ID: 754399 [TBL] [Abstract][Full Text] [Related]
18. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension]. Marzecka J Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117 [TBL] [Abstract][Full Text] [Related]
19. High prevalence of autonomous aldosterone secretion among patients with essential hypertension. Gouli A; Kaltsas G; Tzonou A; Markou A; Androulakis II; Ragkou D; Vamvakidis K; Zografos G; Kontogeorgos G; Chrousos GP; Piaditis G Eur J Clin Invest; 2011 Nov; 41(11):1227-36. PubMed ID: 21534948 [TBL] [Abstract][Full Text] [Related]
20. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism. Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]